Evidence map›Paper›PMID 32186433›Full record

ArticleAutophagy2021

Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5.

Xing Feng, Heng Zhang, Lingbing Meng, Huiwen Song, Qingxin Zhou, Chao Qu, Pan Zhao, Qinghua Li, Chang Zou, Xing Liu and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 176 citations in OpenAlex.

  1. The multifaceted role of 3-methyladenine in cancer therapy.Journal of physiology and biochemistry · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Biomedicines · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. A bibliometric analysis of global research trends in autophagy and glioblastomas.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Xing FengThe Affiliated Hospital of Guilin Medical University, Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guangxi Neurological Diseases Clinical Research Center, Guilin, Guangxi, China.ORCID 0000-0001-8226-3389
Heng ZhangDepartment of Histology and Embryology, Xiang Ya School of Medicine, Central South University, Changsha, China.
Lingbing MengNeurology Department, Beijing Hospital, National Center of Gerontology, Beijing.
Huiwen SongDepartment of Cardiology, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Qingxin ZhouDepartment of Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, China.
Chao QuDepartment of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
Pan ZhaoClinical Medical Research Center, the First Affiliated Hospital of Southern University of Science and Technology, the Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China.
Qinghua LiDepartment of Neurology, the affiliated hospital of Guilin Medical University, Guangxi, China.
Chang ZouClinical Medical Research Center, the First Affiliated Hospital of Southern University of Science and Technology, the Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen, China.
Xing LiuBeijing Neurosurgical Institute, Beijing, China.
Zhiyong ZhangThe Affiliated Hospital of Guilin Medical University, Guangxi Key Laboratory of Brain and Cognitive Neuroscience, Guangxi Neurological Diseases Clinical Research Center, Guilin, Guangxi, China.ORCID 0000-0001-8576-1607
Guilin Medical University · CNJinan University · CNRutgers, The State University of New Jersey · USBeijing Hospital · CNBeijing Institute of Neurosurgery · CNCentral South University · CNJiading District Central Hospital · CNJilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the treatment of brain tumors by targeting kinase-regulated macroautophagy/autophagy, is under investigation, the precise mechanism underlying autophagy initiation and its significance in glioblastoma (GBM) remains to be defined. Here, we report that PAK1 (p21 [RAC1] activated kinase 1) is significantly upregulated and promotes GBM development. The Cancer Genome Atlas analysis suggests that the oncogenic role of PAK1 in GBM is mainly associated with autophagy. Subsequent experiments demonstrate that PAK1 indeed serves as a positive modulator for hypoxia-induced autophagy in GBM. Mechanistically, hypoxia induces ELP3-mediated PAK1 acetylation at K420, which suppresses the dimerization of PAK1 and enhances its activity, thereby leading to subsequent PAK1-mediated ATG5 (autophagy related 5) phosphorylation at the T101 residue. This event not only protects ATG5 from ubiquitination-dependent degradation but also increases the affinity between the ATG12-ATG5 complex and ATG16L1 (autophagy related 16 like 1). Consequently, ELP3-dependent PAK1 (K420) acetylation and PAK1-mediated ATG5 (T101) phosphorylation are required for hypoxia-induced autophagy and brain tumorigenesis by promoting autophagosome formation. Silencing

Indexed as

AutophagyAutophagy-Related Protein 5Brain NeoplasmsCarcinogenesisGlioblastomaGliomaHumansHypoxiap21-Activated KinasesProtein Processing, Post-TranslationalSignal TransductionATG5 protein, humanAutophagy-Related Protein 5p21-Activated KinasesPAK1 protein, humanAcetylationATG5dimerizationELP3glioblastomaPAK1phosphorylationSIRT1ubiquitination

Identifiers

PMID32186433
PMCPMC8032228
OpenAlexW3010853264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.